Home › Funds › Aufman Associates Inc › JNJ

Aufman Associates Inc position in JNJ

JOHNSON & JOHNSON · Health Care

Aufman Associates Inc reported holding 2,564 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$679K, representing 0.28% of its reported portfolio and ranking #27 among its reported holdings. Aufman Associates Inc has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)2.56K sh
Reported value held$678.79K
Portfolio Weight0.28%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Aufman Associates Inc's JNJ position evolved

Aufman Associates Inc first disclosed a stake in JNJ in Q3 2023 at 2,852 shares (US$444K). The position peaked in Q2 2026 at 3,167 shares, worth US$804K. Across 13 filings, Aufman Associates Inc increased the stake 1 time(s), trimmed it 4 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 2,564 shares valued at US$679K — a reduction of -603 shares quarter over quarter.. Notable position changes include a 31% increase in Q3 2024 (shares fell 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.85K $444.20K New
Q4 2023 2.85K $447.02K Hold
Q1 2024 2.85K $451.16K Hold
Q2 2024 2.85K $415.97K Hold
Q3 2024 3.73K $603.84K Add
Q4 2024 3.73K $538.85K Hold
Q1 2025 3.73K $617.92K Hold
Q2 2025 3.72K $568.38K Hold
Q3 2025 3.73K $690.88K Hold
Q4 2025 3.39K $702.39K Reduce
Q1 2026 3.20K $782.94K Reduce
Q2 2026 3.17K $804.32K Reduce
Q3 2026 2.56K $678.79K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Aufman Associates Inc held JNJ?

Aufman Associates Inc has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Aufman Associates Inc's current position in JNJ?

As of Q3 2026, Aufman Associates Inc holds 2.56K shares of JNJ (JOHNSON & JOHNSON), valued at $678.79K, representing 0.28% of its reported portfolio and ranking #27.

Has Aufman Associates Inc been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Aufman Associates Inc reduced its position in JNJ. The position peaked in Q2 2026 at 3.17K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.